Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Lansoprasole
Lansoprasole
103577-45-3
|
369.076
|
2.597
Lansoprazole decreases gastric acid secretion by targeting H+,K+-ATPase. Lansoprazole is used to reduce gastric acid secretion and is approved for short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers.
Lansoprazole | lansoprasole
Lansoprazole decreases gastric acid secretion by targeting H+,K+-ATPase. Lansoprazole is used to reduce gastric acid secretion and is approved for short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers.
Lansoprazole | lansoprasole
$43/5 mg
(EBC)
1
CAS:138530-94-6
0
We provide 0 compound for Lansoprasole